<?xml version="1.0" encoding="UTF-8"?>
<results title="virus">
 <result pre="form in humansNat Rev Microbiol2007514115117203103 2.SoaresEASantosRPPellegriniJASprinzETanuriASoaresMAEpidemiologic and molecular characterization of" exact="human immunodeficiency virus" post="type 1 in southern BrazilJ Acquir Immune Defic Syndr20033452052614657764"/>
 <result pre="systematic review of virologic and biochemical evidenceAIDS Rev20081021222319092977 18.DescampsDCollinGLetourneurFApetreiCDamondFLoussert-AjakaISimonFSaragostiSBrun-VezinetFSusceptibility of" exact="human immunodeficiency virus" post="type 1 group O isolates to antiretroviral agents: in"/>
 <result pre="Infect Dis2008461589159718419495 28.Doualla-BellFAvalosABrennerBGaolatheTMineMGaseitsiweSOliveiraMMoisiDNdwapiNMoffatHet al.High prevalence of the K65R mutation in" exact="human immunodeficiency virus" post="type 1 subtype C isolates from infected patients in"/>
 <result pre="the K65R reverse transcriptase mutation in subtype C variants of" exact="human immunodeficiency virus" post="type 1J Virol2009832029203319073730 38.CoutsinosDInvernizziCFXuHBrennerBGWainbergMAFactors affecting template usage in the"/>
 <result pre="Ouagadougou, Burkina FasoJ Acquir Immune Defic Syndr200849172518667925 45.LoembaHBrennerBParniakMAMa'ayanSSpiraBMoisiDOliveiraMDetorioMWainbergMAGenetic divergence of" exact="human immunodeficiency virus" post="type 1 Ethiopian clade C reverse transcriptase (RT) and"/>
 <result pre="differ from subtype B infectionJ Acquir Immune Defic Syndr20033333634212843744 53.ChaixMLRouetFKouakoussuiKALaguideRFassinouPMontchoCBlancheSRouziouxCMsellatiPGenotypic" exact="human immunodeficiency virus" post="type 1 drug resistance in highly active antiretroviral therapy-treated"/>
 <result pre="Antimicrob Agents20083127728118182278 55.GrossmanZPaxinosEEAverbuchDMaayanSParkinNTEngelhardDLorberMIstominVShakedYMendelsonEet al.Mutation D30N is not preferentially selected by" exact="human immunodeficiency virus" post="type 1 subtype C in the development of resistance"/>
 <result pre="development of resistance to nelfinavirAntimicrob Agents Chemother2004482159216515155216 56.Doualla-BellFAvalosAGaolatheTMineMGaseitsiweSNdwapiNNovitskyVABrennerBOliveiraMMoisiDet al.Impact of" exact="human immunodeficiency virus" post="type 1 subtype C on drug resistance mutations in"/>
 <result pre="a nelfinavir-containing regimenAntimicrob Agents Chemother2006502210221316723586 57.DumansATSoaresMAMachadoESHueSBrindeiroRMPillayDTanuriASynonymous genetic polymorphisms within Brazilian" exact="human immunodeficiency virus" post="Type 1 subtypes may influence mutational routes to drug"/>
 <result pre="mutations on in vitro phenotype, fitness, and replication capacity of" exact="human immunodeficiency virus" post="type 1 with subtype B and C proteasesAntimicrob Agents"/>
 <result pre="resouce-limited West AfricaClin Infect Dis20094847648319143530 68.NtemgwaMLdâ€™Aquin ToniTBrennerBGCamachoRJWainbergMAAntiretroviral drug resistance in" exact="human immunodeficiency virus" post="type 2Antimicrob Agents Chemother2009533611361919470514 69.SyllaMChamberlandABoileauCTraoreHAAg-AboubacrineSCisseMKoalaSDraboJDialloINiambaPet al.Characterization of drug resistance"/>
 <result pre="of antiretroviral resistance in treated Ugandans infected with non-subtype B" exact="human immunodeficiency virus" post="type 1AIDS Res Hum Retrovirus200420355364 75.XuHTMartinez-CajasJLNtemgwaMLCoutsinosDFrankelFABrennerBGWainbergMAEffects of the K65R"/>
</results>
